Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Redhill Biophrma ADR
(NQ:
RDHL
)
6.930
USD
+0.060 (+0.87%)
Official Closing Price
Updated: 4:00 PM EDT, Apr 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
182,600
Open
6.930
Bid (Size)
6.570 (1)
Ask (Size)
7.040 (1)
Prev. Close
6.870
Today's Range
6.710 - 7.080
52wk Range
6.060 - 11.52
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue
April 09, 2021
Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 pneumonia based on review of unblinded...
From
PR Newswire
RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with MSN Pharmaceuticals
March 25, 2021
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that RedHill Biopharma Inc., AztraZeneca AB and AstraZenca Pharmaceuticals LP...
From
PR Newswire
Performance
YTD
-15.18%
-15.18%
1 Month
-7.10%
-7.10%
3 Month
-10.70%
-10.70%
6 Month
-27.66%
-27.66%
1 Year
+0.14%
+0.14%
More News
Read More
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland
March 22, 2021
From
PR Newswire
RedHill Biopharma Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
March 18, 2021
From
PR Newswire
RedHill Biopharma to Host Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights Webcast on March 18, 2021
March 11, 2021
From
PR Newswire
RedHill to Present at Upcoming Conferences in March
March 05, 2021
From
PR Newswire
Add Up The Pieces: BIB Could Be Worth $104
April 20, 2021
Tags
ETFs
From
ETF Channel
RedHill Biopharma Announces Closing of $35 Million Bought Deal Offering of American Depositary Shares
March 04, 2021
From
PR Newswire
5 Israeli Stocks To Consider For Passover
March 27, 2021
Tags
Small Cap
PLTK
BKHYY
From
Benzinga
RedHill Biopharma Ltd. (NASDAQ: RDHL) Featured in Virtual Coverage of the 33rd Annual ROTH Conference
March 16, 2021
From
InvestorBrandNetwork
Could These 2 Exciting COVID Stocks be 10-Baggers?
April 11, 2021
Tags
RDHL
Market News
HGEN
From
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.